Exploring Sodium MRI Contrast Beyond Concentration in Multiple Sclerosis Lesions
Robert Stobbe1, Penny Smyth2, Roxane Billey2, Leah White2, Fabrizio Giuliani2, Derek Emery3, and Christian Beaulieu1

1Biomedical Engineering, University of Alberta, Edmonton, AB, Canada, 2Neurology, University of Alberta, Edmonton, AB, Canada, 3Radiology, University of Alberta, Edmonton, AB, Canada

Synopsis

Two different relaxation-weighted 23Na sequences were compared to density-weighted 23Na imaging in the context of multiple sclerosis (MS) and the lesion contrast produced by each sequence was significantly different, thus identifying the presence of substantial 23Na relaxation change. Given that macromolecular density and structure directly influence the electric field gradients driving orientation of the nuclear electric quadrupole moment and 23Na relaxation, exploration of 23Na relaxation change may help in the assessment of MS including axonal loss and demyelination. The use of relaxation-weighted sequences and their relative combination to eliminate sodium concentration dependence is a starting point for 23Na relaxation exploration.

Purpose

Sodium MRI has been applied to multiple sclerosis (MS) with a focus on sodium concentration measurement, as Na+ ions are involved in axonal injury and demyelination1-4. However, the relaxation mechanism of 23Na, i.e. the alignment of the nuclear electric quadrupole moment in an environment-driven electric field gradient, could also provide novel micro-structural information. Rapid biexponential T2 relaxation with a fast component (T2f) on the order of 1-3 ms is produced in dense and ordered macromolecular environments like myelin. In this study we compare the MS lesion contrast of two different relaxation-weighted 23Na sequences with that of a 23Na density-weighted sequence. We also present the novel relative combination of these relaxation-weighted images to eliminate sodium concentration dependence and highlight the effects of 23Na relaxation change alone in MS lesions.

Methods

Whole brain images were acquired from 10 MS volunteers (48±13 yr; 8F/2M; 5-RRMS/5-PPMS) on a Varian Inova 4.7T MRI. Using a single-tuned birdcage head coil, three 23Na sequences were acquired from each volunteer: (i) a density-weighted sequence – NaDW5 (TR/TE = 85/0.11 ms, flip-angle = 30°, twisted projections TwP = 6000, NEX = 1, 3.2×3.2×6.4 mm3, time = 8.5 minutes); (ii) a ~T2f/T1 sequence – NaPACMAN6 (TR/TE = 25/2.5 ms, flip-angle = 110°, TwP = 6000, NEX = 3, 3.2×3.2×6.4 mm3, time = 7.5 minutes); and (iii) a fluid-suppressed sequence with ~1/(T2f*T1) contrast – NaSIRFLA7 (TR/TI/TE = 150/37/0.22 ms, rectangular inversion pulse = 5 ms, flip-angle = 64o, TwP = 3000, NEX = 1, 4.5×4.5×9.0 mm3, time = 7.5 minutes). Standard FLAIR images (1x1x4 mm3) were acquired as part of a subsequent 1H imaging session (following a 10 minute break). A total of 72 lesions were drawn on the FLAIR images, and these ROIs transferred to the coregistered (SPM) sodium images. The average 23Na signal was measured in each lesion and in a comparable normal appearing (on FLAIR) ROI. A paired t-test was used to test for statistical difference in lesion contrast between sequence types. Linear regression of 23Na signal with lesion volume was also performed. Novel image contrast was created by dividing NaSIRFLA with NaPACMAN to yield approximately inverse T2f dependent contrast without contribution from 23Na concentration.

Results

Compared to non-lesion brain, the average MS lesion signal was increased by 13% for NaDW and 27% for NaPACMAN, but decreased by 6% for NaSIRFLA (example images from one patient in Figure 1). Although there is considerable scatter between lesions, most follow a similar contrast pattern between sequences (Figure 2). The mean contrast difference between NaDW and NaPACMAN is 14% ± 4% (confidence interval), and between NaDW and NaSIRFLA it is -19% ± 4%. Much of the intra-sequence 23Na signal variability can be attributed to lesion volume with larger lesions showing more sodium signal (Figure 3). Large intensity reduction is exhibited in the lesion of the NaSIRFLA/NaPACMAN map with expected inverse T2f-weighting (Figure 4).

Discussion and Conclusion

We show that different types of sodium sequences (i.e. NaDW, NaPACMAN, and NaSIRFLA) produce significantly different MS lesion contrast, and for larger lesions the contrast difference between sequences becomes more pronounced. A probable source of contrast correlation with lesion volume is smearing from rapid signal decay; higher resolution imaging may be required to offset this effect. Alternatively, or in addition, lesion pathology may correlate with lesion volume. The sodium concentration (NaDW) increase in lesions likely reflects an increased extracellular fluid volume fraction. This could result from the loss of macromolecules (e.g. myelin) in the extracellular space, and more severely from cell atrophy or death. Altered cellular Na+ metabolism may also contribute to the NaDW lesion contrast. T2f increase is to be expected with the loss of macromolecular density and structure6. While T2f increase enhances the contrast of NaPACMAN, this increase (along with an expected T1 increase) is sufficient to drive the inversion recovery of NaSIRFLA sufficiently close to the null point so as to overcome the sodium concentration increase. Alternative 23Na sequences and their relative combination (e.g. NaSIRFLA / NaPACMAN - which eliminates sodium concentration dependence) may provide a useful starting point to assess 23Na relaxation change with pathology.

Acknowledgements

National Multiple Sclerosis Society

References

1. Inglese M, Madelin G, Oesingmann N, Babb JS, Wu W, Stoeckel B, Herbert J, Johnson G. Brain tissue sodium concentration in multiple sclerosis: A sodium imaging study at 3 Tesla. Brain. 2010; 133:847-857

2. Maarouf A, Audoin B, Konstandin S, Rico A, Soulier E, Reuter F, Le Troter A, Confort-Gouny S, Cozzone PJ, Guye M, Schad LR, Pelletier J, Ranjeva JP, Zaaraoui W. Topography of brain sodium accumulation in progressive multiple sclerosis. MAGMA. 2014; 27(1):53-62

3. Paling D, Solanky BS, Riemer F, Tozer DJ, Wheeler-Kingshott CA, Kapoor R, Golay X,Miller DH. Sodium accumulation is associated with disability and a progressive course in multiple sclerosis. Brain. 2013; 136:2305-2317

4. Zaaraoui W, Konstandin S, Audoin B, Nagel AM, Rico A, Malikova I, Soulier E, Viout P,Confort-Gouny S, Cozzone PJ, Pelletier J, Schad LR, Ranjeva JP. Distribution of brain sodium accumulation correlates with disability in multiple sclerosis: A cross-sectional 23Na MRI imaging study. Radiology. 2012; 264:859-867

5. Stobbe RW, Beaulieu C, Residual quadrupole interaction in brain and its effect on quantitative sodium imaging. NMR Biomed. 2015.

6. Stobbe RW, Beaulieu C, Exploring and enhancing relaxation-based sodium MRI contrast. MAGMA. 2014; 27(1):21-33

7. Stobbe RW, Beaulieu C, In vivo sodium magnetic resonance imaging of the human brain using soft inversion recovery fluid attenuation. Magn Reson Med. 2005; 54(5):1305-10

Figures

Figure 1: Images from an RRMS MS volunteer demonstrating lesion contrast difference between sodium sequences. The calibration tubes visible on the sides of the head are not part of the current analysis.

Figure 2: For the majority of the 72 lesions, the NaPACMAN contrast is greater than NaDW (76% of all lesions) and the NaSIRFLA contrast is negative (80% of all lesions). Using a paired t-test the contrast differences between sequences were significant (p < 1e-8).

Figure 3: Much of the contrast variation within each sequence type can be attributed to differences in lesion volume. Linear regression yields correction coefficients of R = 0.66 (p ~ 1e-10), R = 0.62 (p ~ 1e-9), and R = -0.38 (p ~ 0.001) for NaDW, NaPACMAN and NaSIRFLA, respectively.

Figure 4: Novel NaSIRFLA / NaPACMAN map with no sodium concentration dependence, but large expected inverse T2f dependence. The intensity in the MS lesion is low in this image map.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
1297